Fiche du document

Date

1 décembre 2023

Périmètre
Langue
Identifiants
Collection

DOAB

Organisation

OAPEN



Citer ce document

Directory of Open Access Books, ID : 10670/1.od6g0z


Métriques


Partage / Export

Résumé 0

Lung cancer continues to be the leading cause of cancer mortality worldwide among both men and women. Recent advances in prevention, screening and management in the past decade have led to significant improvements in survival and quality of life. Local treatments like minimally invasive surgery, radiotherapy, and image-guided ablation have contributed to improving the effectiveness and tolerability of potentially curative treatments in early-stage, locally advanced, and oligometastatic/oligoprogressive disease. Chemotherapy, targeted therapy, immunotherapy, and palliative local therapy options have expanded rapidly, with new regimens showing improved outcomes even for those with widely metastatic disease. This book comprehensively reviews the evidence that has driven personalized medicine, based on a variety of multidisciplinary perspectives by international lung cancer experts.

document thumbnail

Sur les mêmes sujets

Sur les mêmes disciplines

Exporter en